跳至主要内容
临床试验/NCT04967560
NCT04967560已完成不适用

The Efficacy and Safety of Deep Brain Stimulation of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens (ALIC/NAcc-DBS) for Treatment-refractory Obsessive-compulsive Disorder (OCD)

Shanghai Mental Health Center7 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年7月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
7
主要终点
Treatment response rate

研究概览

简要总结

The present study aims to explore the efficacy and safety of DBS targeted the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC/NAcc-DBS) to refractory OCD, based on multicenter, randomized, double-blinded, sham-stimulation controlled design, that could help to obtain stronger evidence of the efficacy of multiple targets.

详细描述

OCD is a chronic and disabled mental disorder, with one third of patients could hardly get recovery from the medication and psychotherapy. Deep brain stimulation (DBS) is a novel potential surgical treatment for refractory OCD, however, the choose of targets are still controversial. This study aims to investigate the therapeutic efficacy and safety of bilateral DBS of the anterior limb of internal capsule and nucleus accumbens (ALIC/NAcc-DBS) for treatment-refractory OCD. In this multicenter, prospective, and double-blinded study, 64 patients with OCD who met the eligibility criteria will be enrolled and randomized allocated to active and sham-stimulation group, followed up for three months after surgery. Then the blind will be uncover, the sham group switch to true stimulation, all patients will be followed up at six months after surgery. The primary outcome was to compare the treatment response rate between the active group and sham-controlled group at the end of three months after surgery. The secondary outcomes include changes in the Yale-brown obsessive-compulsive scale (Y-BOCS), Hamilton anxiety scale (HAMA), Hamilton depression scale (HAMD), and Clinical global impressions (CGI) scale of both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Randomization of DBS are blinded to evaluators, participants, and programming doctors. The programming doctors used the specific software to allocated the participants, that software was preset random coding program to randomized allocate the subjects. The DBS interface of all patients is displayed as a true stimulus, but the true impulse was running in the background controlled by the software, so that even the programming doctors could not know the grouping.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 18-65 years old;
  • a diagnosis of OCD based on The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5);
  • suffered from severe OCD symptoms over 5 years with substantial functional impairment;
  • the Y-BOCS total score ≥ 25;
  • met the criteria of treatment refractory. Treatment refractory is defined as failed 1) at least three adequate therapeutic trials of serotin reuptake inhibitors (SRIs), with clomipramine being one of the SRIs trials, 2) the use of at least two atypical antipsychotics as augmenting agents, 3) at least 12 sessions of therapist-guided cognitive-behavioral therapy while on a therapeutic dose of an SRIs. These patients have "failed" treatment by demonstrating <25% reduction of Y-BOCS scores or, despite >25% reduction in YBOCS score, by still experiencing significant impairment from their illness.

排除标准

  • a history of current or past diagnosis of any psychosis according to DSM-5 except for OCD
  • any clinical significant neurological disorder, traumatic brain injury, dementia, or medical illness
  • any contradiction of neurosurgery
  • any current or unstably remitted substance abuse or dependence
  • women who are pregnant or preparing for pregnant
  • severe suicide risk and tendency according to the investigators' judgements
  • participate in any other clinical trials within three months (except for registered studies).

研究组 & 干预措施

DBS true-stimulation group

Active Comparator

The electrical stimulation will be 'turned-on' immediately after programming in true-stimulation group.

干预措施: deep brain stimulation (Device)

DBS sham-stimulation group

Sham Comparator

The electrical stimulation will be 'turned-off' after programming in sham-stimulation group. The stimulation will begin until after completing three months of Y-BOCS and CGI assessments

干预措施: deep brain stimulation (Device)

结局指标

主要结局

Treatment response rate

时间窗: three month after stimulus

Our primary outcome measure was to compare the treatment response rate (TRR) between the active group and sham-controlled group at the end of three months. (TRR is defined as the number of treatment response/the number of group, a ≥35% reduction in Y-BOCS plus CGI=1or2 met the criteria of treatment response). Note: Y-BOCS, Yale-Brown obsessive-compulsive scale; CGI, clinical global impression.

次要结局

  • the change scores of CGI at double-blinded stage(three month after stimulus)
  • the change scores of HAMD at double-blinded stage(three month after stimulus)
  • the change scores of HAMD at open-label stage(six month after stimulus)
  • the change scores of Y-BOCS at double-blinded stage(three month after stimulus)
  • the change scores of HAMA at double-blinded stage(three month after stimulus)
  • the change scores of HAMA at open-label stage(six month after stimulus)
  • the change scores of Y-BOCS at open-label stage(six month after stimulus)
  • the change scores of CGI at open-label stage(six month after stimulus)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhen Wang

Shanghai Mental Health Center

Shanghai Mental Health Center

研究点 (7)

Loading locations...

相似试验